Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

WINT Stock Forecast, Price Targets, Chart, Dividends & Analysis

Windtree Therapeutics Inc. logo

Windtree Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.32
 
USD
  
0.00
  
(-1.48%)
Previous close: 0.325  Open: 0.3294  Bid: 0.325  Ask: 0.3395
52 week range    
0.32   
   14.75
Mkt Cap: 3 M  Avg Vol (90 Days): 1,701,346
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Sunday 22nd December 2024

Stock Rankings

43
MarketXLS Rank
80
Value
15
Technical
34
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NWBO

NYMX

0.2

OHCS

OMIC

0 B-119.55
Financials

WINT Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends6 M14 M
Amortization of intangibles16 M16 M10 M
Basic EPS from continuing operations-42.0-104.0-136.5-62.23-5.24
Basic EPS total-26.0-399.0-42.0-104.0-136.5-62.23-5.24
Basic weighted shares outstanding2 M139340.0166560.020560.089.0655680.0313080.0495200.0630000.04 M
Cost of sales-3 M-929000.0
Depreciation-800000.0-700000.0-300000.0-192000.0-160000.0-195000.0200000.0192000.0533000.082000.0
DepreciationAndAmortization-800000.0-700000.0-300000.0-192000.0-160000.0-195000.0200000.0192000.0533000.082000.0
Diluted EPS total-28.0-399.0-237.0-1207.0-387.0-42.0-104.0-136.5-62.23-5.24
Diluted weighted shares outstanding2 M139340.0170460.050800.0143820.0655680.0313080.0495200.0630000.04 M
GainOnSaleOfBusiness1 M
GainOnSaleOfPPE-84000.0
GainOnSaleOfSecurity75000.0
GeneralAndAdministrativeExpense-1 M-1000000.0-800000.0-700000.0-800000.012 M15 M14 M11 M9 M
Gross operating profit164000.058000.02 M1 M2 M198000.044000.0
ImpairmentOfCapitalAssets13 M3 M
Income before tax-44 M-55 M-39 M-17 M-19 M-27 M-33 M-78 M-41 M-20 M
Income restructuring and M&A-3 M400000.0
Income taxes-3760.0-2599.0-71 M-5000.01 M-125000.0-10 M-1 M-625000.0
Interest income4000.018000.012000.015000.0153000.0122000.091000.0109000.0325000.0
InterestExpenseNonOperating-5 M5 M3 M2 M1 M495000.0125000.0114000.053000.050000.0
InterestExpenseOperating-3 M-1 M
MiscOtherSpecialCharges-800000.0-11 M1 M6 M-1 M-2 M-2 M-320000.0702000.031000.0
Net income from total operations-44 M-55 M-39 M-17 M-19 M-27 M-33 M-68 M-39 M-20 M
NetIncomeCommonStockholders-44 M-55 M-39 M-23 M-33 M-27 M-33 M-68 M-39 M-20 M
NetIncomeContinuousOperations-44 M-55 M-39 M-17 M-19 M-27 M-33 M-68 M-39 M-20 M
NetNonOperatingInterestIncomeExpense5 M-5 M-2 M-2 M-1 M-342000.0-3000.0-23000.056000.0275000.0
Normalized income-43 M-22 M
Operating income-43 M-40 M-38 M-23 M-16 M-25 M-30 M-77 M-41 M-21 M
Operating income before depreciation (EBITDA)-49 M-59 M-37 M-15 M-16 M-26 M-32 M-77 M-40 M-20 M
OperatingExpense-46 M-41 M-40 M-24 M-18 M25 M30 M77 M41 M21 M
Other income net800000.011 M-1 M-7 M1 M2 M2 M45 M6 M-31000.0
OtherGandA-1 M-1000000.0-800000.0-700000.0-800000.012 M15 M14 M11 M9 M
OtherImpairmentOfCapitalAssets45 M7 M
OtherOperatingExpenses-46 M-41 M-40 M-24 M-18 M-889000.0855000.0902000.0701000.0536000.0
OtherWriteDown-66000.0
OtherunderPreferredStockDividend6 M14 M
PreferredStockDividends6 M14 M
RentAndLandingFees-1 M-1000000.0-800000.0-700000.0-800000.0
Research & development expense27 M29 M32 M17 M11 M13 M15 M18 M11 M8 M
ResearchExpense27 M29 M32 M17 M11 M13 M15 M18 M11 M8 M
RestructringAndMnAIncome-3 M400000.0
Revenue per share-2 M-1 M16 M16 M10 M
SalariesAndWages-3 M-2 M-1 M-2 M-955000.0
Selling Gen & administrative expense17 M11 M8 M7 M7 M12 M15 M14 M11 M9 M
SellingAndMarketingExpense17 M11 M8 M7 M7 M
SellingExpense17 M11 M8 M7 M7 M
Special income/charges3 M-13 M-3 M
Total Income available for interest expense (EBIT)-51 M-61 M-37 M-15 M-17 M-27 M-32 M-78 M-41 M-21 M
Total common shares outstanding821830.0273947.0273947.0273947.0273947.0821830.029174.031632.0909013.09 M
Total net income-44 M-55 M-39 M-17 M-19 M-27 M-33 M-68 M-39 M-20 M
Total ordinary shares9 M9 M9 M9 M9 M9 M9 M9 M9 M9 M
Total revenues3 M987000.02 M1 M2 M198000.044000.0
TotalExpenses-49 M-42 M-40 M-24 M-18 M25 M30 M77 M41 M21 M
TotalRevenue312000.07000.02 M1 M2 M198000.044000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University